These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5754875)

  • 1. [Insulinemic response to various stimuli in normal, obese, diabetic and acromegalic subjects].
    Benedetti A
    Folia Endocrinol; 1968 Feb; 21(1):65-79. PubMed ID: 5754875
    [No Abstract]   [Full Text] [Related]  

  • 2. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. I.R.I. after glucagon administration in groups of obese subjects, with no family history of diabetes, with normal glucose tolerance test, with chemical diabetes, or with mild not ketotic diabetes mellitus.
    Adezati L; Prando R; Cristofolini MP; Pagliaini R
    Acta Isot (Padova); 1970; 10(3):319-32. PubMed ID: 5003714
    [No Abstract]   [Full Text] [Related]  

  • 4. [Behavior of IRI after carbohydrate and aminophylline stimulation in normal, obese and diabetic subjects].
    Quartarone M; Cucinotta D; Longo G; Coglitore G; Squadrito G
    Minerva Med; 1979 May; 70(22):1629-33. PubMed ID: 450302
    [No Abstract]   [Full Text] [Related]  

  • 5. [Some aspects of the dynamic behavior of IRI in obesity and in diabetes mellitus].
    Squadrito G
    Minerva Med; 1979 May; 70(23):1651-8. PubMed ID: 450305
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin sensitivity of blood glucose versus insulin sensitivity of blood free fatty acids in normal, obese, and obese-diabetic subjects.
    Belfiore F; Iannello S; Camuto M; Fagone S; Cavaleri A
    Metabolism; 2001 May; 50(5):573-82. PubMed ID: 11319720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma glucagon and insulin concentrations in acromegaly.
    Trimble ER; Atkinson AB; Buchanan KD; Hadden DR
    J Clin Endocrinol Metab; 1980 Sep; 51(3):626-31. PubMed ID: 6997331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects.
    Bagdade JD; Bierman EL; Porte D
    J Clin Invest; 1967 Oct; 46(10):1549-57. PubMed ID: 6061732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin response to glucose, tolbutamide, secretin, and isoprenaline in maturity-onset diabetes mellitus.
    Deckert T; Lauridsen UB; Madsen SN; Mogensen P
    Dan Med Bull; 1972 Oct; 19(7):222-6. PubMed ID: 5079926
    [No Abstract]   [Full Text] [Related]  

  • 10. [Behavior of the insulinemic response after oral and intravenous administration of glucose in the normal subject and obese diabetic].
    Laudicina E; Bompiani GD; Scaduto P; Cerasola GA; Angileri G
    Folia Endocrinol; 1969 Dec; 22(4):400-16. PubMed ID: 5409263
    [No Abstract]   [Full Text] [Related]  

  • 11. Hormonal and metabolic studies of the action of fenfluramine in normal man, obesity, acromegaly and diabetes mellitus.
    Sulaiman WR; Johnson RH; Rennie MJ
    Postgrad Med J; 1975; 51 Suppl 1():125-31. PubMed ID: 1219669
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of adrenergic beta-blocking agents on the serum insulin and glucagon response to oral glucose load in normal and diabetic subjects].
    Ferlito S; Volpicelli D; Del Campo F; Romano F; Modica L
    Clin Ter; 1981 May; 97(4):333-47. PubMed ID: 6113914
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients.
    Paquot N; Scheen AJ; Dirlewanger M; Lefèbvre PJ; Tappy L
    Obes Res; 2002 Mar; 10(3):129-34. PubMed ID: 11886934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prolactin response to TRH in insulin-dependent diabetes mellitus].
    Gragnoli G; Tanganelli I; Signorini AM
    Boll Soc Ital Biol Sper; 1980 Oct; 56(19):1989-95. PubMed ID: 6779839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the parameters of a compartmental system for the study of the kinetics of plasma glucose and insulin in normal, diabetic, and obese subjects.
    Turco GL; Vercellone G; Pagano PG; Segre G
    J Nucl Biol Med; 1971; 15(1):1-2. PubMed ID: 5127077
    [No Abstract]   [Full Text] [Related]  

  • 16. [Insulin secretion in the early stages of diabetes mellitus (author's transl)].
    Serrano-Ríos M; Ramos F; Vivanco F; Rodriguez-Miñón JL
    Munch Med Wochenschr; 1973 Sep; 115(38):1601-3. PubMed ID: 4800870
    [No Abstract]   [Full Text] [Related]  

  • 17. Response of insulin, glucagon, lactate, and nonesterified fatty acids to glucose in visceral obesity with and without NIDDM: relationship to hypertension.
    Iannello S; Campione R; Belfiore F
    Mol Genet Metab; 1998 Mar; 63(3):214-23. PubMed ID: 9608544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in blood sugar, and insulin levels induced by somatostatin in normal, diabetic and acromegalic subjects].
    Carmina E; Lanzara P; Janní A
    Minerva Med; 1976 Apr; 67(18):1204-4-10. PubMed ID: 934480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of verapamil on glucose, insulin and glucagon levels after oral glucose load in normal and diabetic subjects.
    Ferlito S; Modica L; Romano F; Patané M; Raudino M; Branca S; Costa A
    Panminerva Med; 1982; 24(3):221-6. PubMed ID: 6757844
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects.
    Perley MJ; Kipnis DM
    J Clin Invest; 1967 Dec; 46(12):1954-62. PubMed ID: 6074000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.